Your new post is loading...
Your new post is loading...
Omega-3s moderate blood levels of triglycerides and inflammation – two key drivers of cardiovascular disease (CVD) – and exert beneficial effects on blood pressure and heart rhythms. In addition, it’s likely that omega-3s exert as yet unknown “nutrigenomic” effects on people’s genes. Until now, no one had ever examined the ways in which omega-3s might moderate people’s physiological reactions to stress … some of which promote CVD or are or suspected of doing that.
The drugs, known as non-steroidal anti-inflammatory drugs (NSAIDs), include ibuprofen and diclofenac, and also newer medication called coxibs.
Vegetarians are one-third less likely to be hospitalized or die from heart disease than meat and fish eaters, according to a new UK study. Earlier research has also suggested that non-meat eaters have fewer heart problems, researchers said, but it wasn't clear if other lifestyle differences, including exercise and smoking habits, might also play into that.
According to research, more dietary fiber, but not necessarily less saturated fat or cholesterol, is tied to a lower risk of heart disease and type-2 diabetes in teenagers.
Via Nutritional Info
Low levels of vitamin D may be responsible for the increased risk of heart disease that comes from diabetic people developing clogged up arteries, according to new research.
CNN | A controversial new study shows a "fringe" alternative treatment for heart disease was effective at preventing heart problems. It is no surprise that opponents of chelation (often traditional medical professionals involved in conventional heart disease treatments) attribute the benefits of chelation to chance: >>The AP (11/5, Marchione) reports on a study presented at the American Heart Association meeting in Los Angeles regarding chelation, described as a "treatment that many doctors consider to be fringe medicine unexpectedly showed some promise in a federal study clouded by ethical and scientific controversy, causing debate about the results." The study found that "a chelation mixture...tested in a study of 1,708 heart attack survivors led to fewer complications - repeat heart attacks, strokes, deaths, hospitalization for chest pain or need for an artery-opening procedure." But because of dropouts and incomplete treatments, it is "unclear whether the benefit credited to chelation could have occurred by chance alone." >>The New York Times (11/5, B4, Pollack, Subscription Publication) reports, "To the surprise of many cardiologists, a controversial alternative therapy proved beneficial to people with heart disease, reducing the rate of death and cardiovascular problems in a clinical trial." Yet, "the benefit of the treatment...barely reached statistical significance, and there were questions about the reliability of the study." Still, "the unexpected finding should provide some vindication to the National Institutes of Health for sponsoring the $30 million study." >>USA Today (11/5, Szabo) reports the study "is being called a $32 million waste of time - and even a danger to public health - by some of the country's leading health experts." The study "found a small overall benefit to chelation, mainly because it prevented heart problems in people with diabetes." AHA's Elliott Antman "praised NIH for doing the study," but added that the results "should not be interpreted as an indication to adopt chelation therapy into clinical practice." Cleveland Clinic Cardiologist Steven Nissen, MD, commented, "There are a lot of people, including me, who believe this was a poor use of taxpayer dollars." Lead researcher Gervasio Lamas, Mount Sinai Medical Center in Miami Beach, Florida, said that researchers need to find out whether the indicated benefit "is true, or whether it occurred by chance." It is notable that the study results indicate a probablity of just 2 in 1000 that the positive outcome for diabetics was by chance.
Increased intakes of vitamin K1 may lower the risk of developing type-2 diabetes in elderly people with a high risk of cardiovascular disease, says a new study. There is an irony in these results. Most people over the age of 60 with a risk of cardiovascular disease (and virtually all people over 75) are prescribed warfarin, a blood thinning medication. Vitamin K contributes to clotting. In patients on warfarin, Vitamin K intake is discouraged to make it easier to regulate medication levels and maintain a proper blood flow. Vitamin K is found in many vegetables with additional health properties such as broccoli and leafy greens. If an increase in this vitamin could help lower the risk of diabetes, some patients may have to make a decision whether they can properly regulate their levels on warfarin.
A large Danish study found a strong statistical link between low blood levels of vitamin D and increased risk of heart disease and death. The population study measured baseline vitamin D levels, then followed up over 29 years. The researchers also performed a meta-analysis of 35 additional studies. The team cautions that this is not a causal proof. However, there is a strong link. This could mean either that low vitamin levels indicate poorer health status, or that vitamin D levels do directly affect heart health. The official conclusion of the study "We observed increasing risk of ischemic heart disease, myocardial infarction, and early death with decreasing plasma 25-hydroxyvitamin D levels."
Hundreds of thousands of heart patients could benefit from new blood thinning drugs to cut their risk of stroke. The existing (and popular) blood thinning medications coumadin and warfarin have a number of side effects and require frequent monitoring and often dietary adjustments to maintain proper levels. Alternatives to these drugs, although bound to have their own side effects, could help many patients who require blood thinners to reduce stroke risk.
A new understanding of the immune system may be paving the way for the development of a vaccine for heart disease. “If successful, a tolerogenic vaccine could stop the inflammation component of heart disease,” [Dr. Klaus] stated. “This could probably be used in conjunction with the statins (cholesterol-lowering drugs) that have already taken a significant chunk out of the numbers of people with heart disease. Together, they could deliver a nice one-two punch that could be important in further reducing heart disease.”
A prototype bathroom scale not only measures the user's weight, but also performs an electrocardiogram on them. People who need monitoring for heart conditions may not have to go to the hospital as often for testing, if this new design can be produced for home use.
More people hospitalized for cardiac arrest are surviving compared with a decade ago, according to a U.S. study, possibly because of changes in hospital treatment and the way bystanders respond when somebody collapses. The study found a decrease in death rate of over 10% in people hospitalized after cardiac arrest.
The American Heart Association and other leading health authorities recommend consuming fish oil and fatty fish high in omega-3 fatty acids, for two reasons: 1) To help prevent strokes and cardiovascular disease in healthy people. 2) To reduce the risk of stroke, sudden death, or a second heart attack among patients diagnosed with cardiovascular disease. So consider salmon, mahi mahi, tilapia, or other sustainable fish for your summer grilling protein. They are delicious and will keep your heart healthy, your brain strong, and your eyesight sharp. Sustainable fish guide: http://www.montereybayaquarium.org/cr/cr_seafoodwatch/sfw_recommendations.aspx
|
L-carnitine significantly improves cardiac health in patients after a heart attack, say a multicenter team of investigators in a study published today in Mayo Clinic Proceedings. Their findings, based on analysis of key controlled trials, associate L-carnitine with significant reduction in death from all causes and a highly significant reduction in ventricular arrhythmias and anginal attacks following a heart attack, compared with placebo or control.
Anyone wanting to live longer and cut their risk of suffering from heart disease might want to consider getting a pet. The American Heart Association (AHA) issued a scientific statement on Thursday saying owning a pet may help to decrease a person's risk of suffering from heart disease and is linked with lower levels of obesity, blood pressure and cholesterol.
A mixture of B vitamins, fish oils and plant sterols shows promise in boosting heart health by improving the lipid profile of young people with high levels of cholesterol, according to new research.
A new method of growing cardiac tissue is teaching old stem cells new tricks.
The discovery, which transforms aged stem cells into cells that function like much younger ones, may one day enable scientists to grow cardiac patches for damaged or diseased hearts from a patient’s own stem cells — no matter what age the patient — while avoiding the threat of rejection.
Heart disease is the leading cause of death for both men and women in the United States, accounting for one of every four deaths, according to the Centers for Disease Control and Prevention. It also is very expensive. AHA estimates that annual U.S. medical costs of cardiovascular disease will reach $800 billion by 2030 - nearly triple the $272 billion spent in 2010.
Cardiology | LOS ANGELES — Patients with a prior MI given weekly infusions of chelation therapy experienced fewer CV events than patients who received placebo infusions, according to new results from the TACT trial. Dr. Terry Grossman discusses: Conventional medicine does not typically support chelation as a treatment for heart disease saying there is no good evidence that it works. The results of the TACT (Trial to assess Chelation Therapy) are in. The results were presented at the AHA (American Heart Association) meeting yesterday. This was the first well designed, randomized, double-blind, placebo-controlled trial of chelation therapy EVER and it showed that EDTA chelation therapy resulted in fewer cardiovascular events than placebo – particularly for diabetics. The major benefits were in the reduction of revascularization procedures, likes stents and bypass surgery. The 1/3 of subjects who were diabetic had a hazards ratio of 0.61. so diabetic subjects were 39% less likely to need stenting or bypass if they got chelation than if they got placebo, with a p value of 0.002 (this means a 2 in 1000 probability these results were due to chance).
Reducing sugary drinks, even just a few ounces a day, reduces your risk of blood pressure problems. A study in 2010 found that decreasing the intake of sugar-sweetened beverages (already-known culprits of weight gain) lead to a reduction in blood pressure. Elevations in blood pressure increase the risk of heart disease and stroke. Even a slight reduction, which could be achieved by cutting out 12 oz of sugary beverages per day, can make a difference in terms of heart health risk. Scientists aren't certain why sugar affects blood pressure. One possible explanation is that sugar irritates the artery walls, which may prompts an increase in pressure.
People who had higher levels of a common synthetic chemical in their blood were more likely to have heart disease or have had a stroke, in a new U.S. study. These are preliminary statistics and do not prove that the chemical causes heart disease, but the connection warrants a closer look.
It is commonly understood that when a parent has died of heart disease at a young age (under 60), the offspring have a higher risk of having heart disease. A recent study, which examined data on millions of people in Denmark over a period of 30 years, confirms this theory. In fact, the risk is also increased for individuals with a second-degree relative (grandparent, half-sibling) who died young. And the risk can be compounded-- when two or more first-degree relatives died of heart problems before age 60, a person's own risk of early heart disease rose five-fold. It's important to note that the power of lifestyle changes to offset this potential is not clear. So, while the risk may be increased for individuals with a family history, there is still a very likely benefit to making improvements in blood pressure, cholesterol, exercise, and diet. The increased risk should be used as information and perhaps inspiration to make improvements, but not as a foregone lifespan conclusion.
Cocoa compounds found in dark chocolate can reduce blood pressure in the short term and could help guard against cardiovascular disease, according to a recently released study.
KurzweilAI: Damaged and aged heart tissue of older heart failure patients was rejuvenated by stem cells modified by scientists, according to research presented at the American Heart Association’s Basic Cardiovascular Sciences 2012 Scientific Sessions. The research could one day lead to new treatments for heart failure patients, researchers said.
A retired high-school teacher has become the first person in New England to receive an artificial heart. James Carelli, 66-years-old, was suffering from a rare condition that leads to total heart failure if left untreated. As with many others who have received an artificial heart, the substitute buys Carelli the vital extra time he needs while waiting for the real thing.
|